Home › Acute Biphenotypic Leukemia › Colorado › Denver
Acute Biphenotypic Leukemia clinical trials in Denver, CO
4 studies for Acute Biphenotypic Leukemia are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecruitingPhase 3
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- Colorado Blood Cancer Institute, Denver
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Children's Hospital Colorado, Denver
Acute Biphenotypic Leukemia trials in other cities
- Seattle, WA15 studies
- Houston, TX11 studies
- New York City, NY10 studies
- Atlanta, GA9 studies
- Durham, NC8 studies
- Chicago, IL7 studies
- Memphis, TN7 studies
- Aurora, CO6 studies
- Dallas, TX6 studies
- Philadelphia, PA6 studies
- Baldwin Park, CA6 studies
- Los Angeles, CA6 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma26 studies
- Colorectal Cancer23 studies
- Cancer (all types)19 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Ovarian Cancer16 studies
- Endometrial Cancer16 studies
- Lung Cancer16 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.